2. Academic Validation
  3. Concurrent hyperbaric oxygen therapy and intratympanic steroid application as salvage therapy after severe sudden sensorineural hearing loss

Concurrent hyperbaric oxygen therapy and intratympanic steroid application as salvage therapy after severe sudden sensorineural hearing loss

  • Clin Case Rep. 2016 Feb 11;4(3):287-93. doi: 10.1002/ccr3.510.
Hans Lamm 1,  Claus Müller-Kortkamp 2,  Athanasia Warnecke 3,  Friederike Pohl 1,  Gerrit Paasche 3,  Thomas Lenarz 3,  Stefan R O Stolle 1
Affiliations

Affiliations

  • 1 Department of Otorhinolaryngology Hannover Medical School Carl-Neuberg-Str. 1 Hannover 30625 Germany.
  • 2 Private Practice for Otorhinolaryngology Institute of Hyperbaric Medicine Seilerstr. 7-9 Hannover 29614 Germany.
  • 3 Department of Otorhinolaryngology Hannover Medical School Carl-Neuberg-Str. 1 Hannover 30625 Germany; Hearing 4 all Cluster of Excellence Hannover Germany.
PMID: 27014454 DOI: 10.1002/ccr3.510
Abstract

Concurrent hyperbaric oxygen therapy (HBOT) and intratympanic steroid application (ITS) are beneficial as salvage therapy for therapy-refractory sudden sensorineural hearing loss (SSNHL). The findings encourage further research on the treatment of noise-induced and idiopathic SSNHL with concurrent use of HBOT and ITS respecting also patients with long-term or therapy-refractory SSNHL.

Keywords

Concurrent hyperbaric oxygen therapy; intratympanic steroid application; sudden deafness; sudden sensorineural hearing loss.

Figures